Skip to main content
. 2015 Jun 15;5(7):2180–2189.

Table 1.

Comparison of baseline clinical characteristics based on GPS, NLR, PLR and LMR

Cases (n, %) GPS (n, %) P value NLR (n, %) P value PLR (n, %) P value LMR (n, %) P value




0 1 2 ≤3.45 >3.45 ≤166 >166 ≤2.30 >2.30
Age (years) 0.598 0.410 0.676 0.167
    ≤60 184 (56.4) 110 52 22 119 65 102 82 101 83
    >60 142 (43.6) 77 45 20 98 44 82 60 67 75
Gender 0.449 0.633 0.810 0.704
    Female 43 (13.2) 27 13 3 30 13 25 18 21 22
    Male 283 (86.8) 160 84 39 187 96 159 124 147 136
Tumor length (cm) 0.001 <0.001 0.001 0.304
    ≤3 89 (27.3) 64 22 3 77 12 63 26 50 39
    >3 237 (72.7) 123 75 39 140 97 121 116 118 119
Tumor location 0.179 0.277 0.121 0.146
    Upper 19 (5.8) 9 6 4 11 8 15 4 12 7
    Middle 156 (47.9) 81 52 23 99 57 87 69 72 84
    Lower 151 (46.3) 97 39 15 107 44 82 69 84 67
Vessel invasion 0.136 0.066 0.523 0.635
    Negative 269 (82.5) 161 76 32 185 84 154 115 137 132
    Positive 57 (17.5) 26 21 10 32 25 30 27 31 26
Differentiation 0.333 0.023 0.186 0.079
    Well 50 (15.3) 31 12 7 35 15 28 22 33 17
    Moderate 206 (63.2) 123 60 23 145 61 123 83 102 104
    Poor 70 (21.5) 33 25 12 37 33 33 37 33 37
T stage <0.001 <0.001 0.078 0.059
    T1 59 (18.1) 47 11 1 54 5 42 17 37 22
    T2 60 (18.4) 41 16 3 45 15 34 26 35 25
    T3 175 (53.7) 88 55 32 105 70 92 83 84 91
    T4 32 (9.8) 11 15 6 13 19 16 16 12 20
N stage 0.001 0.007 0.004 0.041
    N0 179 (54.9) 117 48 14 130 49 111 68 103 76
    N1 84 (25.8) 39 33 12 55 29 50 34 41 43
    N2 40 (12.3) 20 12 8 23 17 13 27 17 23
    N3 23 (7.1) 11 4 8 9 14 10 13 7 16